Retatrutide
Triple agonist: GIP/GLP-1/Glucagon receptor agonist. Eli Lilly. Most potent weight loss peptide in clinical trials. Phase 3 trials ongoing.
Overview
Triple agonist: GIP/GLP-1/Glucagon receptor agonist. Eli Lilly. Most potent weight loss peptide in clinical trials. Phase 3 trials ongoing.
Profound appetite suppression, improves fasting glucose and HbA1c, may improve lipid profile more than dual agonists (glucagon component increases energy expenditure), can elevate amylase/lipase, increased heart rate reported, may affect liver enzymes
Compound Guide
Structure: Triple-acting peptide agonist at GIP, GLP-1, and Glucagon receptors. The glucagon receptor activation is unique — increases energy expenditure and hepatic fat oxidation on top of the appetite suppression from GIP/GLP-1.
Dosage:
- Clinical trial dosing: 1mg/week → 2mg/week → 4mg/week → 8mg/week → 12mg/week (titrated monthly)
- Bodybuilding use: Limited data — most users start at 1-2mg/week and titrate based on response
Administration:
- SubQ injection once weekly
- Titrate slowly over weeks/months
Key Notes:
- Phase 3 clinical trials ongoing — not yet FDA-approved (as of 2025)
- Clinical trials showed up to 24% body weight loss at 48 weeks (most potent of any GLP-1 class drug)
- Glucagon receptor activation differentiates it: increases energy expenditure, promotes hepatic fat oxidation
- Triple mechanism may reduce liver fat (NAFLD/NASH) more effectively than dual agonists
- GI side effects expected to be similar to other GLP-1 agonists
- Resting energy expenditure increase from glucagon component is unique and potentially muscle-sparing
- Very limited real-world bodybuilding data — early adopters only
- Monitor: fasting glucose, HbA1c, lipid panel, liver enzymes, amylase/lipase, heart rate
Usage History
Marker Interactions
Frequently Asked Questions
Related Articles
How to Pick Your First Peptide and What to Add After That
Most peptide stacks fail on sequence, not selection. A six-stage roadmap for what to run first, what to add next, and what the evidence actually supports.
How to Test for Heavy Metals in UGL Steroids and Peptides
UGL steroids and grey-market peptides can carry lead, cadmium, and arsenic. Here is which blood tests to order and how to read the results.
Peak Week Carb Loading: Front Load, Back Load or Undulating
How to carb load and fill out for a bodybuilding show, the truth about water loading, electrolyte safety, and what your peak week bloodwork actually shows.
Does 5-Amino-1MQ Actually Burn Fat? (No Human Trials Yet)
5-amino-1MQ is an NNMT inhibitor sold for fat loss and NAD+. Here's the real evidence, honest dosing, and the bloodwork to run on it.
Quick Reference
Category
GLP-1
Half-Life
~6 days
Detection Time
N/A